{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:01:37Z","timestamp":1785420097415,"version":"3.56.0"},"reference-count":42,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.3892\/ijo.2015.3165","type":"journal-article","created":{"date-parts":[[2015,9,14]],"date-time":"2015-09-14T08:18:05Z","timestamp":1442218685000},"page":"1647-1654","source":"Crossref","is-referenced-by-count":10,"title":["Antitumorigenic effect of interferon-\u03b2 by inhibition of undifferentiated glioblastoma cells"],"prefix":"10.3892","volume":"47","author":[{"given":"SHUN","family":"YAMAMURO","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EMIKO","family":"SANO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YUTAKA","family":"OKAMOTO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YUSHI","family":"OCHIAI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TAKASHI","family":"OHTA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AKIYOSHI","family":"OGINO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ATSUSHI","family":"NATSUME","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TOSHIHIKO","family":"WAKABAYASHI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TAKUYA","family":"UEDA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HIROYUKI","family":"HARA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TOMOHIRO","family":"NAKAYAMA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ATSUO","family":"YOSHINO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YOICHI","family":"KATAYAMA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2015,9,14]]},"reference":[{"key":"key20180107190848_b1-ijo-47-05-1647","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ccr.2006.03.030","article-title":"Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines","volume":"9","author":"Lee","year":"2006","journal-title":"Cancer Cell"},{"key":"key20180107190848_b2-ijo-47-05-1647","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nature03031","article-title":"Spatial patterns in species distributions reveal biodiversity change","volume":"432","author":"Wilson","year":"2004","journal-title":"Nature"},{"key":"key20180107190848_b3-ijo-47-05-1647","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ccr.2007.12.005","article-title":"Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells","volume":"13","author":"Lee","year":"2008","journal-title":"Cancer Cell"},{"key":"key20180107190848_b4-ijo-47-05-1647","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ccr.2009.02.011","article-title":"TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma","volume":"15","author":"Pe\u00f1uelas","year":"2009","journal-title":"Cancer Cell"},{"key":"key20180107190848_b5-ijo-47-05-1647","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/nm0909-1010","article-title":"Cancer stem cells: Mirage or reality?","volume":"15","author":"Gupta","year":"2009","journal-title":"Nat Med"},{"key":"key20180107190848_b6-ijo-47-05-1647","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.cell.2011.07.026","article-title":"Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells","volume":"146","author":"Gupta","year":"2011","journal-title":"Cell"},{"key":"key20180107190848_b7-ijo-47-05-1647","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1158\/0008-5472.CAN-13-0109","article-title":"Chromatin regulator PRC2 is a key regulator of epigenetic plasticity in glioblastoma","volume":"73","author":"Natsume","year":"2013","journal-title":"Cancer Res"},{"key":"key20180107190848_b8-ijo-47-05-1647","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"key":"key20180107190848_b9-ijo-47-05-1647","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial","volume":"10","author":"Stupp","year":"2009","journal-title":"Lancet Oncol"},{"key":"key20180107190848_b10-ijo-47-05-1647","first-page":"6119","article-title":"Mammalian O6-alkylguanine-DNA alkyltransferase: Regulation and importance in response to alkylating carcinogenic and therapeutic agents","volume":"50","author":"Pegg","year":"1990","journal-title":"Cancer Res"},{"key":"key20180107190848_b11-ijo-47-05-1647","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1023\/B:NEON.0000024217.68738.11","article-title":"Two different mechanisms of apoptosis resistance observed in interferon-beta induced apoptosis of human glioma cells","volume":"67","author":"Saito","year":"2004","journal-title":"J Neurooncol"},{"key":"key20180107190848_b12-ijo-47-05-1647","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2174\/092986707780059616","article-title":"Perspectives in biomolecular therapeutic intervention in cancer: From the early to the new strategies with type I interferons","volume":"14","author":"Vannucchi","year":"2007","journal-title":"Curr Med Chem"},{"key":"key20180107190848_b13-ijo-47-05-1647","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s11060-004-7316-1","article-title":"Therapeutic implications of interferon regulatory factor (IRF)-1 and IRF-2 in diffusely infiltrating astrocytomas (DIA): Response to interferon (IFN)-beta in glioblastoma cells and prognostic value for DIA","volume":"74","author":"Yoshino","year":"2005","journal-title":"J Neurooncol"},{"key":"key20180107190848_b14-ijo-47-05-1647","doi-asserted-by":"crossref","first-page":"7573","DOI":"10.1158\/0008-5472.CAN-05-0036","article-title":"IFN-beta down-regulates the expression of DNA repair gene MGMT and sensitizes resistant glioma cells to temozolomide","volume":"65","author":"Natsume","year":"2005","journal-title":"Cancer Res"},{"key":"key20180107190848_b15-ijo-47-05-1647","first-page":"1253","article-title":"Potentiation of anti-glioma effect with combined temozolomide and interferon-beta","volume":"16","author":"Park","year":"2006","journal-title":"Oncol Rep"},{"key":"key20180107190848_b16-ijo-47-05-1647","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/jjco\/hyn095","article-title":"A multicenter phase I trial of interferon-beta and temozolomide combination therapy for high-grade gliomas (INTEGRA Study)","volume":"38","author":"Wakabayashi","year":"2008","journal-title":"Jpn J Clin Oncol"},{"key":"key20180107190848_b17-ijo-47-05-1647","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s11060-011-0529-1","article-title":"A multicenter phase I trial of combination therapy with interferon-\u03b2 and temozolomide for high-grade gliomas (INTEGRA study): The final report","volume":"104","author":"Wakabayashi","year":"2011","journal-title":"J Neurooncol"},{"key":"key20180107190848_b18-ijo-47-05-1647","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.canlet.2009.04.020","article-title":"Induction of oligodendrogenesis in glioblastoma-initiating cells by IFN-mediated activation of STAT3 signaling","volume":"284","author":"Yuki","year":"2009","journal-title":"Cancer Lett"},{"key":"key20180107190848_b19-ijo-47-05-1647","first-page":"529","article-title":"Gene expression profiles predicting the response to IFN-\u03b2 and a combination of temozolomide and IFN-\u03b2 in malignant gliomas","volume":"39","author":"Yoshino","year":"2011","journal-title":"Int J Oncol"},{"key":"key20180107190848_b20-ijo-47-05-1647","doi-asserted-by":"crossref","first-page":"e3655","DOI":"10.1371\/journal.pone.0003655","article-title":"CD133 is a marker of bioenergetic stress in human glioma","volume":"3","author":"Griguer","year":"2008","journal-title":"PLoS One"},{"key":"key20180107190848_b21-ijo-47-05-1647","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0165-3806(02)00274-2","article-title":"Evaluation of progenitor cell cultures from human embryos for neurotransplantation","volume":"134","author":"Poltavtseva","year":"2002","journal-title":"Brain Res Dev Brain Res"},{"key":"key20180107190848_b22-ijo-47-05-1647","first-page":"5821","article-title":"Identification of a cancer stem cell in human brain tumors","volume":"63","author":"Singh","year":"2003","journal-title":"Cancer Res"},{"key":"key20180107190848_b23-ijo-47-05-1647","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mod.2004.08.008","article-title":"Pluripotential competence of cells associated with Nanog activity","volume":"122","author":"Hatano","year":"2005","journal-title":"Mech Dev"},{"key":"key20180107190848_b24-ijo-47-05-1647","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0092-8674(03)00393-3","article-title":"The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells","volume":"113","author":"Mitsui","year":"2003","journal-title":"Cell"},{"key":"key20180107190848_b25-ijo-47-05-1647","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20180107190848_b26-ijo-47-05-1647","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nm.2304","article-title":"The cancer stem cell: Premises, promises and challenges","volume":"17","author":"Clevers","year":"2011","journal-title":"Nat Med"},{"key":"key20180107190848_b27-ijo-47-05-1647","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nature05236","article-title":"Glioma stem cells promote radioresistance by preferential activation of the DNA damage response","volume":"444","author":"Bao","year":"2006","journal-title":"Nature"},{"key":"key20180107190848_b28-ijo-47-05-1647","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.canlet.2009.01.016","article-title":"Isolation and characterization of cancer stem like cells in human glioblastoma cell lines","volume":"279","author":"Qiang","year":"2009","journal-title":"Cancer Lett"},{"key":"key20180107190848_b29-ijo-47-05-1647","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1200\/JCO.2000.18.19.3441","article-title":"The art of oncology: When the tumor is not the target. Tell it like it is","volume":"18","author":"Smith","year":"2000","journal-title":"J Clin Oncol"},{"key":"key20180107190848_b30-ijo-47-05-1647","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/ng.159","article-title":"Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation","volume":"40","author":"Kondo","year":"2008","journal-title":"Nat Genet"},{"key":"key20180107190848_b31-ijo-47-05-1647","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/nrc1991","article-title":"Polycomb silencers control cell fate, development and cancer","volume":"6","author":"Sparmann","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"key20180107190848_b32-ijo-47-05-1647","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrc2876","article-title":"Covalent histone modifications--miswritten, misinterpreted and mis-erased in human cancers","volume":"10","author":"Chi","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"key20180107190848_b33-ijo-47-05-1647","doi-asserted-by":"crossref","first-page":"6790","DOI":"10.1158\/1078-0432.CCR-08-1013","article-title":"Regulation of pancreatic tumor cell proliferation and chemoresistance by the histone methyltransferase enhancer of zeste homologue 2","volume":"14","author":"Ougolkov","year":"2008","journal-title":"Clin Cancer Res"},{"key":"key20180107190848_b34-ijo-47-05-1647","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S1476-5586(03)80032-5","article-title":"Poorly differentiated breast carcinoma is associated with increased expression of the human polycomb group EZH2 gene","volume":"5","author":"Raaphorst","year":"2003","journal-title":"Neoplasia"},{"key":"key20180107190848_b35-ijo-47-05-1647","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.stem.2010.08.002","article-title":"Polycomb group proteins: Multifaceted regulators of somatic stem cells and cancer","volume":"7","author":"Sauvageau","year":"2010","journal-title":"Cell Stem Cell"},{"key":"key20180107190848_b36-ijo-47-05-1647","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrg1981","article-title":"Polycomb silencing mechanisms and the management of genomic programmes","volume":"8","author":"Schwartz","year":"2007","journal-title":"Nat Rev Genet"},{"key":"key20180107190848_b37-ijo-47-05-1647","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/nrc2736","article-title":"Polycomb group proteins: Navigators of lineage pathways led astray in cancer","volume":"9","author":"Bracken","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"key20180107190848_b38-ijo-47-05-1647","doi-asserted-by":"crossref","first-page":"11606","DOI":"10.1073\/pnas.1933744100","article-title":"EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells","volume":"100","author":"Kleer","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107190848_b39-ijo-47-05-1647","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/nature01042","article-title":"FGFR-related gene nou-darake restricts brain tissues to the head region of planarians","volume":"419","author":"Cebri\u00e0","year":"2002","journal-title":"Nature"},{"key":"key20180107190848_b40-ijo-47-05-1647","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1182\/blood-2009-03-213496","article-title":"Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells","volume":"114","author":"Fiskus","year":"2009","journal-title":"Blood"},{"key":"key20180107190848_b41-ijo-47-05-1647","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1101\/gad.1524107","article-title":"Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells","volume":"21","author":"Tan","year":"2007","journal-title":"Genes Dev"},{"key":"key20180107190848_b42-ijo-47-05-1647","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ng.621","article-title":"Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders","volume":"42","author":"Ernst","year":"2010","journal-title":"Nat Genet"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2015.3165\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T14:12:57Z","timestamp":1515334377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2015.3165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,14]]},"references-count":42,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,9,14]]},"published-print":{"date-parts":[[2015,11]]}},"alternative-id":["10.3892\/ijo.2015.3165"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2015.3165","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,14]]}}}